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SUMMARY
 
The rapidly dividing small intestinal epithelium is very sensitive to the cyto-
static drug methotrexate. We investigated the regulation of epithelial gene expression in
rat jejunum during methotrexate-induced damage and regeneration. Ten differentiation
markers were localized on tissue sections and quantified at mRNA and protein levels rela-
tive to control levels. We analyzed correlations in temporal expression patterns between
markers. mRNA expression of enterocyte and goblet cell markers decreased significantly
during damage for a specific period. Of these, sucrase-isomaltase (
 

 
62%) and CPS (
 

 
82%)
were correlated. Correlations were also found between lactase (
 

 
76%) and SGLT1 (
 

 
77%)
and between I-FABP (
 

 
52%) and L-FABP (
 

 
45%). Decreases in GLUT5 (
 

 
53%), MUC2
(
 

 
43%), and TFF3 (
 

 
54%) mRNAs occurred independently of any of the other markers. In
contrast, lysozyme mRNA present in Paneth cells increased (
 

 
76%). At the protein level,
qualitative and quantitative changes were in agreement with mRNA expression, except for
Muc2 (
 

 
115%) and TFF3 (
 

 
81%), which increased significantly during damage, following
independent patterns. During regeneration, expression of each marker returned to control
levels. The enhanced expression of cytoprotective molecules (Muc2, TFF3, lysozyme) during
damage represents maintenance of goblet cell and Paneth cell functions, most likely to
protect the epithelium. Decreased expression of enterocyte-specific markers represents de-
creased enterocyte function, of which fatty acid transporters were least affected.
 
(J Histochem Cytochem 50:1525–1536, 2002)
 
T
 
he use
 
 of the cytostatic drug methotrexate (MTX)
in anti-cancer treatments severely impairs intestinal
epithelial function, which constitutes a major dose-
limiting factor in treatment schedules (Fata et al.
1999; Kohout et al. 1999). Like 
 

 
-irradiation, this
drug induces diarrhea and anorexia, which is associ-
ated with malabsorption, malnutrition, and dehydra-
tion (Pinkerton et al. 1982). It is of great importance
to unravel the response of the small intestinal epithe-
lium to cytostatic agents at the biochemical level so as
to gain insight in the functional properties of the epi-
thelial cells during damage and subsequent regenera-
tion.
As a folic acid analogue, the action of MTX pri-
marily inhibits DNA synthesis by binding to the en-
zyme dihydrofolate reductase (Werkheiser 1961). This
leads to an inhibition of proliferation in the crypts of
the small intestine (Goldman and Matherly 1985). It
has been demonstrated in biopsy specimens from hu-
man cancer patients that epithelial damage in the
small intestine caused by chemotherapy can be identi-
fied via increases in apoptosis in the crypts, epithelial
changes in cell height and crypt height, and the mani-
festation of villous atrophy (Keefe et al. 2000).
In our rat model of chemotherapeutic damage and
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regeneration in the small intestinal epithelium, four
phases could be discriminated after the two-dose ad-
ministration (IV) of 20 mg/kg plus 10 mg/kg body
weight MTX (Verburg et al. 2000). In this model,
days 1 and 2 represented damage in the crypt epithe-
lium, which was characterized by increased apoptosis
as well as decreased crypt depth and cell height. Days
3 and 4 represented a phase of prominent damage to
the villous epithelium, marked by reduced cell and vil-
lous heights as well as accumulating goblet cells at the
tips of the small intestinal villi. Days 5 and 6 repre-
sented a phase of regeneration via increased prolifera-
tion during which the morphological appearance of
the epithelial cells returned to normal. Days 8 and 10
represented a phase of regenerated small intestinal ep-
ithelium, which was indistinguisable from that of un-
treated rats (Verburg et al. 2000).
Studies have been performed with the use of partic-
ular growth factors, such as TGF (Booth et al. 2000),
KGF (Booth and Potten 2001), EGF (Petschow et al.
1993; Hirano et al. 1995) and IGF (Howarth et al.
1998), that aimed to protect the small intestinal epi-
thelium against radiation injury or damage by cyto-
static drugs. For example, the prophylactic adminis-
tration of transforming growth factor 
 

 
 (TGF
 

 
) was
able to decrease proliferation in the stem cell region
before radiation injury, which resulted in enhanced
crypt survival and enhanced recovery in mice (Booth
et al. 2000). In addition, therapeutic administration,
but not prophylactic administration, of epidermal
growth factor (EGF), insulin-like growth factor (IGF-I),
and TGF
 

 
 has been shown to stimulate epithelial pro-
liferation in the regeneration phase after radiation- or
MTX-induced injury in mice (Petschow et al. 1993;
Hirano et al. 1995; Potten et al. 1995; Howarth et al.
1998). Therefore, although these growth factors are
important for enhanced recovery of the small intesti-
nal epithelium, they fail to prevent or reduce the de-
velopment of the initial damage.
The functions of intestinal epithelial cells are re-
flected by the expression of cell type-specific genes.
Very little is known about the absorptive and pro-
tective functions of epithelial cells during damage and
regeneration induced by chemotherapy. Sucrase–iso-
maltase and lactase, responsible for intestinal disaccha-
ridase activities, were decreased during MTX-induced
damage in rat small intestine (Taminiau et al. 1980;
Kralovanszky and Prajda 1985). In contrast, the amino
acid transporter Pept1 appeared resistant to damage in
the ileum of 5
 

 
-fluorouracil (5-FU)-treated rats (Tanaka
et al. 1998). Furthermore, MTX-treatment appeared
to affect the various populations of epithelial cell types
differently. Relative to enterocytes, epithelial goblet
and Paneth cells were spared from cell death in rat
small intestine after MTX treatment (Verburg et al.
2000). Very little is known about the contribution of
these specialized cell types to epithelial protection dur-
ing such a response.
In the present study, the functional capacities of the
epithelial cells were investigated during MTX-induced
damage and repair, through analysis of the expression
of a range of differentiation markers. The following
markers were used for enterocytes: carbamoylphosphate
synthase (CPS), sucrase–isomaltase (SI), lactase, glu-
cose transporter-5 (GLUT5), sodium glucose co-trans-
porter 1 (SGLT1), intestinal- and liver fatty acid-bind-
ing protein (I-FABP and L-FABP, respectively). For
goblet cells the markers mucin (MUC2) and trefoil fac-
tor 3 (TFF3) were investigated and lysozyme was used
to study Paneth cell function. The jejunum was chosen
as a representative for the small intestine, because
morphology and proliferation were similarly affected
along the small intestinal axis in this model (Verburg
et al. 2000). Epithelial gene expression was quantified
at the mRNA and protein levels and compared with
the immunohistochemical localization of the protein
at sequential days after MTX treatment.
 
Materials and Methods
 
Animals
 
Six-week-old male Wag/Rij rats (Broekman; Utrecht, The
Netherlands) were kept under specific pathogen-free condi-
tions with free access to water and defined semi-synthetic
chow (Hope Farms; Woerden, The Netherlands). Glucose,
starch, and cellulose constitute the carbohydrates in the
food: 424 g/kg, 140 g/kg, and 45 g/kg, respectively. On anal-
ysis, no other carbohydrates were found. The folic acid con-
tent was 0.98 mg/kg. The dosage schedule of MTX treat-
ment was defined during pilot studies. At day 
 

 
1, 20 mg/kg
body weight methotrexate (MTX, Ledertrexate SP forte; Cy-
anamid Benelux, Etten-Leur, The Netherlands) was injected
IV under light anesthesia. At 24 hr later (day 0), a second in-
jection of 10 mg/kg body weight MTX was given. Control
animals received equivalent volumes of 0.9% (w/v) sodium
chloride solution both times. At days 1, 2, 3, 4, 5, 6, 8, and
10 after the second dose of MTX, three rats were sacrificed
by decapitation after anesthesia. Three control animals were
sacrificed at day 8. The experiments were performed with
permission of the Animal Ethics Committee of our institu-
tion. Jejunal segments (anatomic middle of the small intes-
tine) were rinsed in PBS, fixed in 4% (w/v) paraformalde-
hyde (Merck; Darmstadt, Germany) in PBS, and processed
for immunohistochemistry according to standard procedures
(Verburg et al. 2000). In addition, adjacent intestinal seg-
ments (0.5 cm long) were frozen in liquid nitrogen and
stored at 
 

 
80C for quantitative mRNA and protein anal-
ysis.
 
Immunohistochemistry
 
Expression and localization of protein were detected using
immunohistochemistry according to standard procedures
(Verburg et al. 2000). Antigen unmasking was carried out
by heating the sections for 10 min in 0.01 M sodium citrate
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(pH 6.0) at 100C. Endogenous peroxidase activity was
blocked by treatment with 1.5% H
 
2
 
O
 
2
 
 in PBS for 30 min.
Nonspecific protein binding was blocked using a buffer con-
taining 10 mM Tris (pH 8.0), 5 mM ethylenediamine tet-
raacetic acid (Merck), 0.15 M NaCl (Fluka Chemie; Zwijn-
drecht, The Netherlands), 0.25% (w/v) gelatin (Merck), and
0.05% (w/v) Tween-20 (Merck). All sections were incubated
overnight at 4C using one of the primary antibodies diluted
in PBS (Table 1). The antibodies raised against human
SGLT1 (Yoshida et al. 1995), human MUC2 (Tytgat et al.
1995a,b), and human lysozyme (Dako; Glostrup, Denmark)
were shown to be specific in rat. Antibody binding was
visualized using biotin-labeled secondary antibodies and
Vectastain, an avidin–biotin–peroxidase complex detection
kit, according to the manufacturer’s instructions (Vector Lab-
oratories; Burlingame, CA). All sections were recorded and
analyzed using a CCD camera (Sony) and an Eclipse E800
Microscope (Nikon; Tokyo, Japan). Appropriate control
staining was performed, leaving out each of the primary an-
tibodies, which resulted in complete absence of staining for
each separate antibody at the dilutions used in our experi-
ments (Table 1).
 
mRNA Quantitation
 
Total RNA was isolated from frozen tissue using Trizol re-
agent (Gibco-BRL; Gaithersburg, MD). Ten 
 

 
g of total
RNA was run on 1% or 1.2% (w/v) agarose gels containing
0.5 M glyoxal (Boehringer Mannheim; Mannheim, Ger-
many) and blotted overnight onto Hybond-N
 

 
 membranes
(Amersham; Poole, UK). Serial dilutions of each RNA sam-
ple were analyzed to ensure that the mRNA quantification,
of each marker mRNA, using its cognate cDNA probe, was
performed within the linear range of this technique. All blots
were baked for 2 hr at 80C and hybridized using rat-spe-
cific, 
 

 
[
 
32
 
P]-dATP-labeled cDNA probes. The following rat-
specific cDNA probes were used: CPS (Nyunoya et al.
1985), SI (Krasinski et al. 1994), lactase (Büller et al. 1990),
SGLT1 (Burant et al. 1994), GLUT5 (Rand et al. 1993),
I-FABP (Alpers et al. 1984), L-FABP (Gordon et al. 1983),
MUC2 (Verburg et al. 2000), TFF3 (Suemori et al. 1991),
and lysozyme (Yogalingam et al. 1996). Each probe hybrid-
 
ized to an mRNA band of the appropriate molecular weight
as originally described for the respective probes. Moreover,
all bands were clear and discrete, and no signs of RNA deg-
radation were observed. After exposure for 1 or 2 days to
PhosphorImager plates, the hybridization signals were quan-
tified using a PhosphorImager and ImageQuant software
(Molecular Dynamics/Amersham; Roosendaal, The Nether-
lands). Expression was corrected for the amount of glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) mRNA, which
served as internal standard.
 
Protein Quantitation
 
Changes in epithelial protein expression were determined in
tissue homogenates using quantitative Western blotting. Tis-
sue was homogenized in HEPES buffer [20 mM HEPES
(Merck), pH 7.5, 20 mM NaCl (Boehringer), 0.5% (w/v)
Triton X-100 (BDH; Poole, UK)] containing 10 
 

 
g/ml pep-
statin A (Sigma; St Louis, MO), 10 
 

 
g/ml leupeptin (Sigma),
1 mM phenylmethylsulfonyl fluoride (Sigma), and 0.38 U/ml
aprotinin (Sigma) as protease inhibitors, using a Polytron
(Kinematica AG; Basel, Switzerland). Ten 
 

 
g of total protein
was separated on 7% or 15% (w/v) SDS-PAGE and blotted
for 1 hr onto Hybond
 

 
 membranes. Serial dilution series of
the protein samples were analyzed to ensure that the quantifi-
cation of each protein by its cognate antibody was performed
in the linear range of this technique. Routine staining of the
SDS-PAGE gels for protein after blotting showed complete
transfer of the proteins to the membrane. After incubation for
1 hr in blocking buffer [Tris pH 7.8 (Merck), 2 mM CaCl
 
2
 
(Merck), 5% (w/v) low-fat milk powder (Nutricia; Wagenin-
gen, The Netherlands), 0.05% (w/v) Triton X-100 (BDH),
and 0.05% (v/v) Antifoam (Sigma)], the blots were incubated
overnight at 4C with one of the primary antibodies (Table 1).
After rinsing in blocking buffer, the blots were incubated for 2
hr in blocking buffer, containing 0.1 
 

 
Ci/ml 
 
125
 
I-labeled pro-
tein A (Amersham). After rinsing three times in Tris buffer
(pH 7.8), the blots were dried and exposed to PhosphorIm-
ager plates for 3 days. Each individual protein marker yielded
clear and reproducible protein bands at the expected molecu-
lar weight as described in the original publications (Table 1).
Signals were quantified as described above.
 
Table 1
 
Antibodies to detect intestinal epithelial proteins
 
a
 
Dilution
Antigen Western Blotting IHC Type
Rat CPS 1:1000 1:5000 r-polyclonal (Gaasbeek Janzen et al. 1984)
Rat SI
 
b
 
— 1:6000 r-polyclonal (Yeh et al. 1991)
Rat SI
 
b
 
1:100 — m-monoclonal (Quaroni and Isselbacher 1985)
Rat GLUT5 1:500 1:1000 r-polyclonal (Rand et al. 1993)
Rat I-FABP 1:1000 1:4000 r-polyclonal (Rubin et al. 1989)
Rat L-FABP 1:1000 1:4000 r-polyclonal (Rubin et al. 1989)
Rabbit SGLT1 — 1:1000 m-monoclonal (Hwang et al. 1991)
Rat MUC2
 
b
 
1:1000 — r-polyclonal (Tytgat et al. 1995b)
Human MUC2
 
b
 
— 1:100 m-monoclonal (Podolsky et al. 1986)
Rat TFF3 1:200 1:6000 r-polyclonal (Suemori et al. 1991)
Human lysozyme — 1:50 r-polyclonal (this study)
 
a
 
Each antibody was shown to be specific in rat (see Materials and Methods for additional references).
 
b
 
Except for SI and MUC2, the same antibodies were used for both Western blotting and immunohistochemistry. r, rabbit; m, mouse.
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Statistical Analysis
 
Changes in mRNA and protein expression levels during
damage and regeneration were statistically analyzed using
the Mann–Whitney 
 
U
 
-test. The statistical correlation coeffi-
cient (rho) between mRNA and protein expression and be-
tween morphological parameters and mRNA/protein ex-
pression was analyzed using Spearman’s test, based on data
from the individual rats. Similarly, correlation coefficients
between the various mRNAs/proteins were used to study co-
ordinate gene expression. In all tests, 
 
p
 
	
 
0.05 was consid-
ered statistically significant.
 
Results
 
The Model
 
Using this animal model, we have shown previously
that we could induce characteristic cytotoxic damage
to the intestinal epithelium of rats by a 2-day treat-
ment with MTX (Verburg et al. 2000). As noted in
this previous study, the pattern of damage and regen-
eration varied slightly among individual animals. As it
appeared, data were most clearly presented by pooling
the data obtained from animals of two consecutive
time points to correct for the observed temporal varia-
tions. Data are presented from four characteristic win-
dows in the course of damage and regeneration, as de-
scribed earlier (Verburg et al. 2000). Days 1–2 after
the last MTX injection were characterized as a period
of inhibited proliferation, severe cell damage in the
small intestinal crypt epithelium, and decreased crypt
depth. Villous height was slightly decreased, but the
villous epithelial cells appeared normal. Days 3–4
were characterized by hyperproliferation, crypt regen-
eration, and villous atrophy. The villous epithelial
cells were depleted and appeared flattened. During
days 5–6, villous regeneration occurred, whereas pro-
liferation gradually returned to normal. Regeneration
was complete on days 8–10.
Basically, the response to MTX was similar in each
region of the small intestine (Verburg et al. 2000, and
results not shown). Therefore, only representative
data of the jejunum are shown here. There were no
macroscopic or microscopic lesions in the epithelium
at any time during the course of damage and regenera-
tion (not shown). It should therefore be noted that the
epithelial barrier was not breached and there was no
apparent denuding of the mucosa during the experi-
ment. This was particularly relevant for the changes in
the expression patterns of the enterocyte markers,
which were basically expressed within the same vil-
lous epithelial cells. Therefore, the relative changes in
quantitative gene expression patterns of the individual
markers were measures of specific gene regulation un-
der these circumstances. In addition, it is noteworthy
that the correlation analyses between quantitative
data regarding gene expression were calculated using
the data for each marker of the individual animals.
 
Enterocytes
 
Immunohistochemistry was performed to study the
fate of enterocytes during the experiment and to local-
ize enterocyte-specific protein expression. Because a
very sensitive but non-linear detection method was
used to visualize binding of antibodies, staining inten-
sities were not quantitatively interpreted throughout
the study. In control rats, CPS protein was expressed
in a mosaic pattern and was localized in series of adja-
cent enterocytes both in crypt and in the villous epi-
thelium (Figure 1A). On days 1–2 most of the crypts
were not stained for CPS, but the protein was still
present in the villous region (Figure 1B). On days 3–4,
CPS protein expression was less abundant on the villi
compared to controls and rats of days 1–2. Part of the
enterocytes on the villous tips showed CPS immunore-
activity during this period of severe villous damage,
but the crypt and villous enterocytes were mostly CPS-
negative (Figure 1C). On days 5–6, the mosaic pattern
of CPS had returned on part of the villi, and the ex-
pression pattern was fully restored on days 8–10 (Fig-
ure 1D).
SI was found in the brush border and in the Golgi
region of villous enterocytes in control rats (Figure
1E). The estimated number of SI-positive villous cells
decreased according to the length of the villi, and dur-
ing the phase of damage on days 1-4 the intracellular
Golgi staining was absent (Figures 1F and 1G). Very
few SI-positive cells were seen on days 3–4, during
maximal villous damage on the tips of the rudimen-
tary villi (Figure 1G). As the villi increased in length
during regeneration, the localization of SI-positive
cells returned to normal (Figure 1H).
Like SI, GLUT5 and SGLT1 proteins were localized
in the brush border of villous enterocytes in control
tissue (Figures 1I and 1M). The estimated numbers of
GLUT5- and SGLT1-positive villous enterocytes de-
creased gradually towards the tips of the shortening
villi during days 1–4 until both markers were unde-
 
Figure 1
 
Immunohistochemical detection of proteins expressed in jejunum enterocytes during different phases of MTX-induced damage
and regeneration. The following enterocyte-specific proteins were detected; CPS (
 
A–D
 
), SI (
 
E–H
 
), GLUT5 (
 
I–L
 
), SGLT1 (
 
M–P
 
), I-FABP (
 
Q–T
 
),
and L-FABP (
 
U–X
 
). (
 
A,E,I,M,Q,U
 
) Control sections. (
 
B,F,J,N,R,V
 
) Sections at 2 days after MTX treatment. (
 
C,G,K,O,S,W
 
) Sections at 4 days after
MTX treatment. (
 
D,H,L,P,T,X
 
) Tissue 8 days after MTX treatment. Arrows in 
 
E
 
 and 
 
H
 
 indicate staining of the Golgi complex by the anti-SI an-
tibodies. Bar 
 


 
 200 
 

 
m.
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tectable on day 4 (Figures 1K and 1O). From day 6
onwards, expression patterns of SGLT1 and GLUT5
were similar to those found in controls (Figures 1L
and 1P).
I-FABP and L-FABP expression was localized in the
cytoplasm of all villous enterocytes in controls (Fig-
ures 1Q and 1U). MTX-induced changes in expression
were similar for both FABP proteins. These changes
were much less pronounced than for the brush border
markers SI, GLUT5, and SGLT1. Despite the increas-
ing villous cell damage up to 4 days after MTX treat-
ment, I-FABP and L-FABP immunostaining remained
present in enterocytes of the remaining villous entero-
cytes (Figures 1R, 1S, 1V, and 1W). As in controls,
I-FABP and L-FABP were expressed in all villous en-
terocytes on days 5–10 (Figures 1T and 1X).
Lactase mRNA levels could be detected as an en-
terocyte marker, but lactase protein could not be lo-
Figure 2 Immunohistochemical detection of proteins expressed in jejunum goblet or Paneth cells during different phases of MTX-induced
damage and regeneration. MUC2 (A–D) and TFF3 (E–H) were detected in goblet cells, whereas lysozyme (I–L) was detected in Paneth cells.
(A,E,I) Control sections. (B,F,J) Sections at 2 days after MTX treatment. (C,G,K) Sections at 4 days after MTX treatment. (D,H,L) Tissue 8 days
after MTX treatment. Arrows in C and G indicate goblet cells accumulated at the tips of the rudimentary villi 4 days after MTX treatment.
Sections in E–L were briefly stained with hematoxylin. Bars: A 
 200 m; I 
 100 m.
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calized using the available antibodies because of its
very low expression levels in these adult rats (Rings et
al. 1994, and data not shown).
 
Goblet and Paneth Cells
 
The fate of goblet and Paneth cells was studied by im-
munohistochemistry for secretory products produced
specifically by these cells. In contrast to the enterocyte
markers, the markers for these cell types appeared to
largely persist throughout the course of damage and
regeneration. MUC2 was stained in the goblet cells at
all time points during the experiment, and MUC2-posi-
tive goblet cells were also expressing TFF3 (Figure 2).
The estimated number of MUC2- and TFF3-positive
cells was decreased compared with controls during
days 1–2 along the crypt–villous axis during the in-
creasing villous atrophy (Figures 2B and 2F). This was
followed around day 4 by a depletion of MUC2- and
TFF3-positive cells in the lower villous region and an
accumulation of MUC2- and TFF3-positive cells in the
villous tip region (Figures 2C and 2G). During regen-
eration, MUC2 and TFF3 expression became compa-
rable with controls (Figures 2D and 2H).
Paneth cells in the crypts were lysozyme-positive at
all days analyzed. A transient induction of lysozyme
immunostaining was seen during crypt damage on days
1–2 (Figures 2I and 2J), which gradually returned to
normal staining patterns on days 3–4 and beyond
(Figures 2K and 2L).
 
Expression of Enterocyte-specific mRNAs
 
The expression of cell type-specific mRNA was quan-
tified by Northern blotting for each individual rat, as
shown in Figure 3A. Pooling of quantitative data from
two consecutive time points was performed to mini-
mize intra-animal variations and to accentuate the dif-
ferences between markers during the course of dam-
age and regeneration (Figure 4).
The changes in mRNA expression of each entero-
cyte marker had a characteristic pattern in time (Fig-
ure 4A). However, the level of each enterocyte mRNA
returned to levels that were not significantly different
from control levels at days 8–10 after MTX treatment.
We performed correlation analysis on changes in the
mRNA levels of these markers on the data from each
individual animal. Four types of patterns could be dis-
tinguished, based on temporal differences in sensitivity
to MTX treatment. Within each type, the expression
patterns of the markers were highly correlated, whereas
there were no statistically significant correlations with
the expression patterns of the markers from any other
type. We could distinguish type 1, CPS and SI; type 2,
SGLT1 and lactase; type 3, I-FABP and L-FABP; and
type 4, GLUT5 (Figure 4). Of these, CPS and SI mRNAs
were most affected at an early stage. During minimal
crypt depth on days 1–2, levels of CPS and SI mRNA
expression were 82% and 62% decreased, respec-
tively, compared with controls (Figure 4A). During
maximal villous damage on days 3–4, CPS and SI were
still significantly decreased, but the levels recovered
relatively rapidly compared to the other markers.
SGLT1 and lactase mRNA levels were the most af-
fected at a later stage, at maximal villous damage on
days 3–4 and recovered more slowly compared to CPS
and SI (Figure 4A). The expression of SGLT1 and lac-
tase mRNA was already significantly decreased on
days 1–2 compared with control (
 

 
50%). This de-
crease progressed to days 3–4, when SGLT1 and lac-
tase mRNAs were hardly detectable (
 

 
77% and
 

 
76%, respectively). In contrast to CPS and SI
mRNAs, SGLT1 and lactase mRNAs were still signifi-
cantly decreased on days 5–6.
I-FABP and L-FABP mRNA levels were markedly
less affected than the previous four markers and were
first significantly affected at maximal villous damage,
whereas the mRNA levels recovered relatively late and
more slowly compared to CPS, SI, SGLT1, and lactase
(Figure 4A). Expression levels of I-FABP and L-FABP
mRNAs decreased significantly on days 3–4 at 52%
and 45%, respectively (Figure 4A). As for SGLT1 and
lactase, regeneration within the tissue was not imme-
diately associated with a normalization of I-FABP and
L-FABP mRNA expression, because both markers
were still significantly decreased on days 5-6.
In contrast to all other enterocyte markers, the
mRNA levels of GLUT5 were only affected significantly
Figure 3 Representative Northern blots (A) and Western blots (B)
demonstrating the expression of selected small intestinal markers.
Days after MTX treatment are indicated above the graphs. C, con-
trol. All results are shown for one rat at each time point. At right
are the sizes of the mRNA (in kilobases, A) and the proteins (in kilo-
daltons, B).
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during one specific phase of disease, i.e., at maximal
villous damage (days 3–4, 
 

 
53%), and recovered rap-
idly during regeneration (Figure 4A).
We analyzed the relations between the level of ex-
pression of each marker and the crypt depth and vil-
lous atrophy, measured as described previously (Ver-
burg et al. 2000). CPS and SI mRNA expression levels
were correlated to changes in crypt depth (rho
 


 
0.399
and rho
 


 
0.432, respectively; 
 
p
 
	
 
0.05) as well as vil-
lous height (rho
 


 
0.377 and rho
 


 
0.483, respectively;
 
p
 
	
 
0.05). The temporal patterns of expression levels
of lactase, GLUT5, SGLT1, I-FABP, and L-FABP
mRNA did not correlate with the variations in crypt
depth or villous height.
 
Expression of Goblet and Paneth Cell-specific mRNAs
 
The response of each of the markers for the goblet and
Paneth cells was very specific and was different from
any of the changes seen for the enterocyte markers
(Figures 3A and 4A). MUC2 mRNA expression was
significantly but inversely correlated to crypt depth
(rho
 


 
0.610; 
 
p
 


 
0.001). During early damage on days
1–2, MUC2 mRNA levels remained stable. Thereafter,
MUC2 mRNA levels were significantly decreased and
remained below control levels up to days 8–10 (Figure
4B). MUC2 and TFF3 protein co-localized to the same
cells (Figure 2). Interestingly, though, TFF3 mRNA lev-
els were not significantly correlated to MUC2 mRNA
levels. TFF3 mRNA levels were decreased only on days
3–4 relative to controls (Figure 4B).
Lysozyme mRNA levels were significantly increased
(
 

 
76%) at early stages of damage on days 1–2 (Figure
4B), in agreement with the immunohistochemical lo-
calization of the protein (Figure 2J), and were rapidly
normalized on days 3–6. There was no significant cor-
relation with any of the morphological parameters.
Surprisingly, a second induction of lysozyme mRNA
levels occurred on days 8–10 (Figure 4B) despite the
seemingly normal lysozyme protein expression at the
immunohistological level (Figure 2L).
Expression Levels of Epithelial Proteins
Temporal expression patterns of epithelial proteins
were quantified on Western blots, as illustrated in Fig-
ure 3B, and compared with expression patterns of the
encoding mRNAs. Despite our efforts we were not
able to quantify the protein levels of all markers.
Therefore, we were not able to quantify SGLT1, lac-
tase, and lysozyme protein due to lack of antibodies
that were able to reproducibly detect these antigens on
Western blotting.
The protein expression level of each enterocyte
marker showed a specific pattern in time. Correlation
analysis, determined from the data of the individual
rats, revealed significant correlations between protein
expression levels and the cognate mRNA levels of
CPS (rho
0.520; p
0.01), SI (rho
0.900; p

0.037), I-FABP (rho
0.482; p
0.015), and L-FABP
(rho
0.591; p
0.001), but not of GLUT5.
Two isoforms of the CPS protein were detected us-
ing these polyclonal antibodies, as described earlier
(Figure 3B; Gaasbeek Janzen et al. 1984). CPS protein
levels were significantly decreased on days 3–6,
whereas CPS protein was significantly increased com-
pared with controls on days 8–10, in accordance with
the changes in mRNA levels (Figures 4A and 4C). SI
protein levels were 50% decreased during days 1–2,
parallel to the decreased mRNA levels, and remained
decreased on days 3–4. SI protein was increased to
control levels on days 5–10 (Figure 4C).
Figure 4 Relative changes in epithelial mRNA and protein expres-
sion in the jejunum after MTX treatment. Panels indicate the
mRNA levels of enterocyte (A) and of goblet and Paneth cell mark-
ers (B) as detected by Northern blotting, and of the protein levels
of enterocyte (C) and of goblet and Paneth cell markers (D) as de-
tected through Western blotting. Control levels, defined as 100%,
were set at 0 on the horizontal axis. The relative in-/decrease, ex-
pressed as percentage of control levels, was analyzed on days 1–2
(black bars), days 3–4 (crosshatched bars), days 5–6 (open bars), and
days 8–10 (gray bars). Closely correlated expression patterns could
be distinguished in enterocyte-specific mRNAs as indicated by
brackets (indicated is the correlation coefficient rho, according to
Spearman’s test): between CPS and SI (rho
0.536; p
0.008), be-
tween SGLT1 and lactase (rho
0.616; p
0.001), and between
I-FABP and L-FABP (rho
0.686; p	0.0005). LAC, lactase, LYS,
lysozyme. Error bars indicate SEM. Asterisks indicate statistically
significant differences relative to control levels at p	0.05.
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I-FABP and L-FABP protein levels tended to de-
crease compared with controls from day 3 onwards,
but only L-FABP protein decreased significantly on
days 5–6 (Figure 4C). On days 8–10, expression of
both FABP protein levels was not statistically different
from controls. As shown in Figure 4C, GLUT5 protein
levels tended to increase during the early phase of
damage on days 1–2, but levels were dramatically de-
creased on days 3–4 compared with controls. During
regeneration, GLUT5 protein expression was rapidly
increased, as it was in the range of control levels on
days 5–10, in line with GLUT5 mRNA expression
(Figures 4A and 4C).
In goblet cells, protein levels were not significantly
correlated with the levels of the encoding mRNAs.
MUC2 as well as TFF3 protein levels were signifi-
cantly increased during all phases of damage despite
the reduced mRNA levels (Figures 4B and 4D). In con-
trast to MUC2, TFF3 protein remained significantly
elevated on days 8–10. Despite the overall similarity in
response to MTX, there was no significant correlation
between Muc2 and TFF3 protein levels, based on the
analysis of the data from the individual rats.
Discussion
The loss of small intestinal epithelial cells and the oc-
currence of villous atrophy caused by MTX has been
well described and has been appreciated since the
1970s (Altmann 1974; Jeynes and Altmann 1978).
The unexpected diversity in our study regarding tem-
poral expression patterns of 10 epithelial gene prod-
ucts in response to MTX indicates the involvement of
specific regulation distinct and independent from ex-
tensive cell loss.
There are strong indications from our results and
from previously published data (Taminiau et al. 1980;
Kralovanszky and Prajda 1985; Tanaka et al. 1998)
that glucose absorption is severely impaired during
MTX-induced damage owing to the absence of impor-
tant proteins, thereby contributing to malabsorption
symptoms. SI and SGLT1 contribute to the digestion
of starch and the absorption of glucose, the primary
carbohydrate sources in the diet of the rats in our
study. Because both SI and SGLT1 were significantly
decreased during damage, these glucose-based energy
sources cannot be efficiently utilized. The physiologi-
cal importance of the absence of carbohydrate diges-
tion and absorption is underscored by the loss of body
weight that occurs up to day 4 after MTX treatment
(Verburg et al. 2000).
Decreased expression of SGLT1 mRNA during
damage is in agreement with previous findings using
5-FU as cytostatic drug (Tanaka et al. 1998). How-
ever, our data also demonstrated that SGLT1 mRNA
was still significantly decreased during regeneration
on days 5–6, when the length of the intestinal villi and
the morphology of the epithelial cells appeared nor-
mal. At this time the epithelium was still in a higher
proliferative state than controls (Verburg et al. 2000).
Most likely, decreased SGLT1 expression was a result
of incomplete differentiation of enterocytes. As a con-
sequence, absorption of free glucose and sodium by
SGLT1 was very likely impaired during damage as
well as during regeneration. Defects in sodium absorp-
tion probably contribute to the development of diar-
rhea, which occurs during days 2–6 after MTX treat-
ment (Verburg et al. 2000).
Glycohydrolase expression, measured by SI and
lactase mRNA and SI protein, was significantly corre-
lated with villous height. The decreased expression of
these brush border proteins during villous damage
confirms previous findings (Taminiau et al. 1980;
Kralovanszky and Prajda 1985). The significant corre-
lation between SI protein and mRNA indicates that SI
expression was primarily transcriptionally regulated,
in agreement with previous work on SI gene regula-
tion (Traber et al. 1992; Krasinski et al. 1994).
GLUT5 is responsible for the uptake of fructose.
Fructose, which was absent from the diet in the
present study, induces GLUT5 mRNA and protein ex-
pression (Corpe et al. 1998). GLUT5 mRNA and pro-
tein expression levels were significantly decreased only
during the phase of severe villous damage. If fructose
were added to the diet as a carbohydrate source, it
could have have stimulatory effects on GLUT5 expres-
sion during intestinal damage and regeneration, which
could contribute to energy uptake to prevent malnour-
ishment in the MTX-treated rat.
The strong correlation between crypt depth and
CPS mRNA expression was in line with the fact that
CPS mRNA is expressed exclusively by crypt entero-
cytes, whereas the protein is also found in villous en-
terocytes (Van Beers et al. 1998). The time lag be-
tween the decrease in CPS mRNA and protein levels
can also be explained by their different localization
pattern along the crypt–villous axis. A role for this mi-
tochondrial protein in the intestinal urea cycle has
been demonstrated by Davis and Wu (1998). These
authors showed, in post-weaning pig enterocytes, that
CPS favors the net synthesis of citrulline from ammo-
nia, HCO3, and ornithine. Thus far, a contribution
of intestinal CPS to the systemic nitrogen balance by
the consumption of ammonia may be underestimated
compared to hepatic CPS. Our findings, however,
could explain the reported hyperammonemia of pa-
tients treated with cytostatic drugs (Fine et al. 1989;
Liaw et al. 1993).
Several functions have been reported for the cytoso-
lic fatty acid-binding proteins in epithelial cells, as re-
viewed by Storch and Thumser (2000). Their role in
the uptake and transport of fatty acids is important in
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the regulation of cell membrane fatty acid levels and
intracellular fatty acid concentrations that modulate
fatty acid-responsive genes. Despite the relative slow
recovery during regeneration, the expression of
I-FABP and L-FABP mRNAs and proteins was the
least affected among the panel of our enterocyte mark-
ers during the phase of crypt damage and villous dam-
age. This was underscored using immunohistochemis-
try. Thus, the FABPs were relatively resistant to damage
compared with carbohydrate-metabolizing enzymes
and transporters and are probably important for
maintaining membrane integrity and fatty acid ab-
sorption in villous enterocytes. This indicates that
fatty acids are potentially important as an energy
source for use during cytostatic drug treatment. The
strong correlation between I-FABP and L-FABP gene
expression suggests that both genes were co-ordinately
regulated under this physiological state. Furthermore,
because of the strong correlations between mRNA
and protein levels, expression of both FABP proteins
appeared transcriptionally regulated after MTX treat-
ment.
In general, the presence and functionality of goblet
cells and Paneth cells were preserved during the MTX-
induced pathology. The expression patterns of MUC2,
TFF3, and lysozyme indicated a generally enhanced
secretion of cytoprotective molecules by goblet cells
and Paneth cells during MTX-induced damage. Secre-
tion of mucin and trefoil factor molecules is known to
contribute to protection of the epithelium via a mu-
cous layer (MUC2) and by promoting epithelial resti-
tution (TFF3) (Dignass et al. 1994). During all phases
of damage (days 1–4) the observed changes in goblet
cell-specific mRNA expression did not reflect the
changes in protein expression either for MUC2 or for
TFF3. At early time points (days 1–2), the stable
MUC2 and TFF3 mRNA expression was associated
with highly increased protein expression. During vil-
lous atrophy (days 3–4), the decreased MUC2 and
TFF3 mRNA expression was associated with in-
creased protein expression. The reduced mRNA levels
and increased protein levels can be explained by the
loss of epithelial goblet cells, as we previously de-
scribed (Verburg et al. 2000), and the involvement of
post-transcriptional regulatory mechanisms that allow
enhanced secretion of mucin and trefoil factor mole-
cules. However, it is in contrast with the observation
of Xian and colleagues, who reported no significant
changes in TFF3 mRNA expression and significant de-
creased TFF3 protein expression in the proximal je-
junum of MTX-treated rats during damage (Xian et
al. 1999). Technically, the study of Xian et al. was
performed differently by giving three SC injections of
MTX, using different antibodies against TFF3, and
using ribonuclease protection assays instead of North-
ern blots for analysis of mRNA expression. In addi-
tion, these authors had selected for another small
intestinal region and another rat strain (Sprague–
Dawley). They did not detect TFF3 protein during
maximal damage, either immunohistochemically or
on Western blotting, in contrast to our findings.
Therefore, it is most likely that the intensity of dam-
age was more severe in the study of Xian et al., lead-
ing to a much more decreased goblet cell function
than in our study.
Despite the overall similarities in MUC2 and TFF3
protein and mRNA levels, no significant correlations
were found in their levels of gene expression during
MTX-induced damage and regeneration. This sug-
gests that both genes were not co-ordinately regulated
in goblet cells in response to chemotherapeutic dam-
age, confirming recent work of others (Matsuoka et
al. 1999).
The defense provided by Paneth cells is likely to act
locally in the crypt micro-environment, e.g., in the
area of the stem cells, via the secretion of a variety of
crypt defensins and peptides that enhance innate mu-
cosal immunity (Wilson et al. 1999). The MTX-induced
increase in lysozyme mRNA expression and lysozyme
immunostaining, seen on days 1–2 confirmed our pre-
vious findings (Verburg et al. 2000) and probably rep-
resents an adaptive response in Paneth cells to contrib-
ute to increased protection, during the vulnerable
stages of the crypt epithelium.
In our study, an unexpected diversity in responses
to MTX was observed between the 10 epithelial gene
products. In particular, the remaining villous entero-
cytes during villous atrophy show a markedly specific
response regarding their gene expression. These mori-
bund cells appear to go through a programmed set of
events that may be destined to maintain optimal epi-
thelial performance during this stressed situation.
Clinically, it may be possible to take advantage of
these pre-programmed decisions by the absorptive epi-
thelial cells to maintain optimal nutritional status in
patients treated with cytostatic drugs. The central im-
portance of the epithelial barrier function and the abil-
ity to regenerate after serious insults is reflected by the
response of goblet cells and Paneth cells, in producing
mucus, trefoil peptides and bactericidal peptides. The
intestine thus reacts very specifically and diversely to
severe damage or noxes and it appears very important
to understand the different mechanisms involved in
order to tailor enteral nutrition for patients treated
with cytostatic drugs.
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